Delivery Order SPE2DR25D1100-SPE2DR26FCX3F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,512.00 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100 count units) under a firm fixed price contract. The delivery order, issued on December 30, 2025, with an ultimate completion date of December 31, 2025, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract was awarded without a set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $2,995.68 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by December 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $9,683.84 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10, with completion targeted for December 29, 2025. This competitively awarded, firm fixed price contract utilizes no set-aside designation and calls for performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units, with a ceiling value of $4,916.56. The contract is a firm fixed price delivery order with an ultimate completion date of June 30, 2025, and was awarded on a competitive, non-set-aside basis. The vendor will perform this work from its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. This contract, valued at $2,497.20 with a firm fixed price structure, represents a small delivery order with an ultimate completion date of December 16, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a $9,988.80 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This firm fixed price, non-set-aside contract is scheduled for ultimate completion on December 16, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $2,820.63 and an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside delivery order performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCX3FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count units) with a firm fixed price ceiling value of $6,048.00. The contract, which is non-set-aside and competitively awarded, is scheduled for ultimate completion by January 5, 2026. AmerisourceBergen will perform the work at its Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Oseltamivir supply under this delivery order contributes to the broader antiviral medication inventory maintained through the DLA's Medical Supply Chain to support federal health readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 1/1/26 |